Many Americans not getting breast, cervical, colon cancer screenings
the ONA take:
According to a study published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, researchers have found that many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Specifically, results showed that among adults in the age groups recommended for screening, approximately one in four women not up to date with breast cancer screening, one in five women were not up to date with cervical cancer screening, and two in five were not up to date with colon cancer screening.
Of note, colon cancer screening rates were stagnant from 2010 to 2013 and cervical cancer screening using the Pap test in women 21 to 65 years of age was lower in 2013 than in 2000. In addition, mammography screenings changed minimally from previous years.
"It is often difficult to get patients to comply with screening tests, especially when they are uninsured or underinsured," said Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City. However, healthcare providers need to convince patients that early screening can improve outcomes.
Many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Sign Up for Free e-newsletters
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|